Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Banking.
Press releases published on April 21, 2025
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
GlobeNewswire
·
April 21, 2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …
SKYWORKS SOLUTIONS, INC. (NASDAQ: SWKS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Skyworks Solutions, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Skyworks Solutions, Inc. (NASDAQ: SWKS)? Did you purchase your shares between July 30, 2024 and February 5, 2025, inclusive? Did you lose money in your …
ROCKET LAB USA, INC. (NASDAQ: RKLB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Rocket Lab USA, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Rocket Lab USA, Inc. (NASDAQ: RKLB)? Did you purchase your shares between November 12, 2024 and February 25, 2025, inclusive? Did you lose money in your …
ENCORE ENERGY CORP. (NASDAQ: EU) DEADLINE ALERT: Bernstein Liebhard LLP Reminds enCore Energy Corp. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of enCore Energy Corp. (NASDAQ: EU)? Did you purchase your shares between March 28, 2024 and March 2, 2025, inclusive? Did you lose money in your investment …
ULTRA CLEAN HOLDINGS, INC. (NASDAQ: UCTT) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ultra Clean Holdings, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Ultra Clean Holdings, Inc. (NASDAQ: UCTT)? Did you purchase your shares between May 6, 2024 and February 24, 2025, inclusive? Did you lose money in your …
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI)? Did you purchase your shares between May 8, 2023 and May 7, 2024, inclusive? Did you lose money in your …
PERPETUA RESOURCES CORP. (NASDAQ: PPTA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Perpetua Resources Corp. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Perpetua Resources Corp. (NASDAQ: PPTA)? Did you purchase your shares between April 17, 2024 and February 13, 2025, inclusive? Did you lose money in your …
PX Energy, an Expanding Vertically Integrated Refinery and Mining Operation Located in Southern Brazil, Intends to Go Public Through a Business Combination with Papaya Growth Opportunity Corp. I, Including a Committed $10 Million Investment
GlobeNewswire
·
April 21, 2025
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- PX Energy (“PX” or the “Company”), a vertically-integrated refined products manufacturer serving the Brazilian market for refined oil and agricultural grade products (through its parent company, Forbes …
VIATRIS INC. (NASDAQ: VTRS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Viatris Inc. Investors of Upcoming Deadline
GlobeNewswire
·
April 21, 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Do you, or did you, own shares of Viatris Inc. (NASDAQ: VTRS)? Did you purchase your shares between August 8, 2024 and February 26, 2025, inclusive? Did you lose money in your investment in Viatris Inc.? Do you …
Immunovant Announces Next Phase of Growth with Roivant Including Changes to its Leadership Team and Additional Indications Sjögren’s Disease (SjD) and Cutaneous Lupus Erythematosus (CLE) for IMVT-1402
GlobeNewswire
·
April 21, 2025
Eric Venker, M.D. (currently President and COO of Roivant) appointed as CEO of Immunovant and Tiago Girao appointed as CFO of Immunovant Pete Salzmann, M.D. retired from his role as Immunovant CEO and Director Leadership change is part of a broader …
AMG Announces Investment in Verition Fund Management
GlobeNewswire
·
April 21, 2025
AMG to acquire a minority equity interest in Verition, a global multi-strategy investment firm with $12.6 billion in AUM Verition’s management will retain a substantial majority of the firm’s equity and continue to lead Verition as an independent firm, in …
HTX Launches Million USDT Airdrop Event to Reward New and Existing Users
GlobeNewswire
·
April 21, 2025
SINGAPORE, April 21, 2025 (GLOBE NEWSWIRE) -- HTX, a leading global cryptocurrency exchange, has announced the launch of its Million USDT Airdrop Event, designed to give back to loyal users and welcome new participants. Running from 09:00 (UTC) on April 18 …
Blue Moon Metals Appoints Boi Linh Doig as Vice-President, Mining
GlobeNewswire
·
April 21, 2025
TORONTO, April 21, 2025 (GLOBE NEWSWIRE) -- Blue Moon Metals Inc. (“Blue Moon” or the “Company”) (TSXV: MOON; OTCQX: BMOOF), is pleased to announce the appointment of Boi Linh Doig as Vice-President, Mining, as it continues to build out its management team …
Castellum, Inc. Reduces Principal Balance by $2 Million on Notes Payable to Robert Eisiminger and Extends Maturity Date
GlobeNewswire
·
April 21, 2025
VIENNA, Va., April 21, 2025 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) ("Castellum" or "CTM"), a cybersecurity, electronic warfare, and software engineering services company focused on the federal government, announces that it has entered …
Kraken Robotics Schedules 2024 Financial Results Release and Webcast
GlobeNewswire
·
April 21, 2025
ST. JOHN'S, Newfoundland and Labrador, April 21, 2025 (GLOBE NEWSWIRE) -- Kraken Robotics Inc. (“Kraken” or the “Company”) (TSX-V: PNG, OTCQB: KRKNF) announces that it will release fiscal year 2024 financial results at 6:30am ET on Monday, April 28, 2025. …
Affimed Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement
GlobeNewswire
·
April 21, 2025
MANNHEIM, Germany, April 21, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it has received a written notice (the “ …
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewswire
·
April 21, 2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger …
Alumis and ACELYRIN Announce Amended Merger Agreement
GlobeNewswire
·
April 21, 2025
ACELYRIN stockholders to receive increased ownership in the combined company through revised exchange ratio; Alumis and ACELYRIN stockholders to now own approximately 52% and 48%, respectively, of the combined company on a fully diluted basis Merger …
Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis
GlobeNewswire
·
April 21, 2025
Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% BROOMFIELD, Colo., April 21, 2025 ( …
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
GlobeNewswire
·
April 21, 2025
VANCOUVER, British Columbia, April 21, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …